Locus Biosciences logo

Locus Biosciences

ID: 5311921

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

8

Funding Rounds

$117.5m

Money raised

Overview

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Locus Biosciences has raised a total of $59m in funding over 8 rounds.

Key Insights:

  • Locus Biosciences Series B round, May 18, 2022: $35m
  • Locus Biosciences Series A round, November 2017: $19m
  • Lous Biosciences , July 2017: $5m
  • Locus Biosciences Venture round, April 2020: $20m
  • Locus Biosciences Grant (money), November 2020: $12.5m
  • Locus Biosciences Series A Funding Round November 2017: $19m
  • Locus Biosciences Series A Funding Round July 2018: $7m
  • Locus Biosciences Grant (money), August 2020: $3k